Wei-Wu He, Director at CASI Pharmaceuticals, Inc. (CASI), bought 100,000 shares at $1.95 ($195K) on 2017-10-10, disclosed to the SEC on 2017-10-11.
Open-market purchase of $195k CASI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| CASI | BUY | 2021-08-20 | $614K | — | Filing → |
| CASI | BUY | 2021-03-30 | $12.3M | — | Filing → |
| CASI | BUY | 2020-11-24 | $976K | — | Filing → |